Skip to content

Zevra Therapeutics, Inc. ZVRA Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$21.95M-2.6%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$301K+90.5%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$23M-16.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$38.59M-23.0%
PVL
Palvella TherapeuticsPVLA
$528K
Arrowhead Research logo
Arrowhead ResearchARWR

Other financials

Income statement

See full
Revenue$36.2M+77.5%
Gross profit$34.3M+80.1%
Operating income$52.1M+1,073%
Net income$37.9M+1,323%
EPS (diluted)$0.60+1,100%

Balance sheet

See full
Cash & equivalents$95.6M+156%
Total debt$1.1M-98.1%
Total equity$205.8M+402%
Total assets$278.6M+61.3%

Cash flow

See full
Operating cash flow$6.1M+175%
CapEx$35.0K-64.6%
Free cash flow$6.1M+173%

Valuation

See full
Market cap$773.23M+56.4%
Enterprise value$678.78M+30.8%
P/E6.2×
P/S6.3×-5.9×

Profitability

See full
Gross margin86.1%+7.2pp
Operating margin-103.9%-43.0pp
Net margin101.6%+60.1pp
FCF margin-75%-30.5pp

Returns & leverage

See full
Return on equity100.7%+60.3pp
Debt / equity-1.5×
Current ratio4.9×+1.9×

Where this comes from

Reported directly by Zevra Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zevra Therapeutics, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zevra Therapeutics, Inc.'s operating lease ROU assets?
Zevra Therapeutics, Inc. (ZVRA) reported operating lease ROU assets of $1.09M in Q1 2026.
How has Zevra Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
Zevra Therapeutics, Inc.'s operating lease ROU assets decreased by 33.6% year-over-year, from $1.64M to $1.09M.
What is the long-term trend for Zevra Therapeutics, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s operating lease ROU assets has grown at a -2.1% compound annual growth rate (CAGR), from $1.35M to $1.21M.
What does operating lease ROU assets mean?
This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.